Li Dean Y bought RXRX
January 2, 2025 · Form 4 insider transaction
Li Dean Y bought 1,647 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,647
Price
$0.00
Total value
N/A
InsiderLi Dean Y
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2025
Filing dateJanuary 6, 2025
Shares owned after77,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.